10th May 2006 10:51
Hikma Pharmaceuticals Plc10 May 2006 Hikma publishes further information about the form and terms of its GDRs LONDON, 10 May 2006 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX:HIK), the multinational pharmaceuticals group, has today published furtherinformation about the form and terms of its Global Depository Receipts (GDRs)listed on the Dubai International Financial Exchange (DIFX). This information can be found at www.difx.ae/market_information/hikma_informational_documents.html. - ENDS - Enquiries: Hikma Pharmaceuticals PLC Susan Ringdal +44 20 7479 4893 Investor Relations Director Brunswick Group Jon Coles / Wendel Verbeek / Justine McIlroy / Alex Tweed +44 20 7404 5959 About Hikma Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: Generic, Branded and InjectablePharmaceuticals. Hikma's operations are based principally in the United States,the Middle East and North Africa ("MENA") region and Europe. In 2005, the Grouphad revenue of $262 million and profit attributable to shareholders of $44million. At 31 December 2005, the Group had over 1,800 employees. For news andother information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals